B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
about
B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.Prognostic significance of B7-H3 expression in patients with colorectal cancer: A meta-analysis.The future of immune checkpoint cancer therapy after PD-1 and CTLA-4.Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma.Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer.Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy.Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis.Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells.B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway.
P2860
Q36464312-310D2534-FEBA-440A-950B-46B7FE4AED5FQ37148928-BEC8E15A-92C7-41E6-BA46-279AA09F2602Q37362510-C33A9AF1-4092-43CB-AD6C-3F9A48F9B293Q37563260-ED26CB0F-1226-49FD-B395-5B1B38ABADF8Q38666253-2743DA93-2C98-4D76-9E3D-1DE57BB6FD89Q38832039-B1719696-BE2B-4A50-A141-FAE82EE7EDE9Q38909198-F692457C-53E9-4EB7-BFEC-F25E06A19B27Q39160982-7F25746C-67D4-4D01-B824-18B400CCBA66Q39987020-F2C69D99-2C83-4292-AC35-2F3DFA434254Q41809391-217E0849-A3DF-4539-9784-C541FA7DAE04Q47150218-6B06A070-0803-44F9-BE7A-25663FE8F9B3Q47426456-576D6648-9B8B-4952-BD81-81E65BC9E6A4Q48089252-0A1C1A88-C303-4704-A092-5F62AFB4F016Q48131888-2EFD1A97-AF9B-4365-916A-5FF5CA6180FDQ53800920-0B2F6BB1-E2FB-428B-8312-FE3EFB695DC0
P2860
B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
B7-H3 expression in colorectal ...... parameters and patient outcome
@ast
B7-H3 expression in colorectal ...... parameters and patient outcome
@en
B7-H3 expression in colorectal ...... parameters and patient outcome
@nl
type
label
B7-H3 expression in colorectal ...... parameters and patient outcome
@ast
B7-H3 expression in colorectal ...... parameters and patient outcome
@en
B7-H3 expression in colorectal ...... parameters and patient outcome
@nl
prefLabel
B7-H3 expression in colorectal ...... parameters and patient outcome
@ast
B7-H3 expression in colorectal ...... parameters and patient outcome
@en
B7-H3 expression in colorectal ...... parameters and patient outcome
@nl
P2093
P2860
P50
P356
P1433
P1476
B7-H3 expression in colorectal ...... parameters and patient outcome
@en
P2093
Kjetil Boye
Vibeke A Ingebrigtsen
Øystein Fodstad
P2860
P2888
P356
10.1186/1471-2407-14-602
P407
P577
2014-08-20T00:00:00Z
P5875
P6179
1027316768